Parental knowledge and attitudes toward HIV preventive treatment for their adolescent children

HIV pre-exposure prophylaxis (PrEP), a daily regimen of two medications in a single pill, could prevent many new HIV infections, especially in at-risk populations. For example, research shows PrEP could prevent around 70 percent of new HIV infections in adolescent cisgender sexual minority males (ASMM) and transgender and gender diverse adolescents (TGDA), populations that are disproportionately affected by the disease. However, despite growing awareness of PrEP among ASMM/TGDA, uptake of the treatment is still less than 5 percent.